Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Gabapentin Dementia Lawsuit Gabapentin dementia lawsuits are being investigated against Pfizer and other drug manufacturers following studies linking the widely prescribed medication to an increased risk of dementia, Alzheimer's disease and mild cognitive impairment. Learn about the allegations, recent research, lawsuit updates and potential settlement compensation.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
OpenFDA Promises Free, Open Access to Vital Health Data June 3, 2014 Irvin Jackson Add Your CommentsOn Monday, the U.S. Food and Drug Administration (FDA) launched a new initiative designed to give researchers and the public access to millions of reports involving problems associated with side effects of different drugs. ย OpenFDA.gov is designed to allow researchers, industry, web developers and the public to easily access the FDA’s adverse event reporting system and other health databases. The move is part of an executive order by President Barack Obama to make government records more accessible to the public and to increase transparency.The adverse event drug data includes 3 million documents dating back to 2004. The website, currently in beta, expects to add data on medical devices and foods in the near future.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATION“These publicly available data sets, once successfully integrated and analyzed, can provide knowledge and insights that cannot be gained from any other single source,” said Taha A. Kass-Hout, M.D., chief health informatics officer and director of FDA’s Office of Informatics and Technology Innovation, in an FDA blog. “Researchers, scientists, software developers, and other technically-focused individuals in both the private and public sectors have always been invited to mine that publicly available data set — and others — to educate consumers, which in turn can further our regulatory or scientific missions, and ultimately, save lives. But obtaining this information hasn’t always been easy.”As presented, the database requires a high level of skill to use and to extract information. It is currently mostly useful to those familiar with JSON documents and API databases. However, the FDA says the data will allow software developers to create new applications, such as mobile phone apps and websites, that will allow the public easy access to the data. It also will eliminate the need for hundreds of Freedom of Information Act (FOIA) requests each year.Data Helps Spot Drug ProblemsA number of groups already mine the FDA adverse event data for information and provide analysis to the public, including the Institute for Safe Medication Practices (ISMP).ISMP releases quarterly reports on trends in adverse drug events, and is often the first to note emerging safety problems with new medications or classes of drugs. The group was the first to warn of growing adverse event reports with the smoking cessation drug Chantix, and the blood thinner Pradaxa, for example. In both cases, the analysis preceded a wave of public concern over the drugs and product liability lawsuits against the drug makers for failing to adequately warn about potential risks.Pradaxa (dabigatran) was first approved by the FDA in October 2010, for the prevention of strokes among patients with atrial fibrillation. It was the first in a new class of blood thinners designed to compete with warfarin, also known by the brand name Coumadin, which had dominated that market for decades.Shortly after its release, ISMP noted that Pradaxa was racking up a large number of adverse event complaints by doctors and patients involving controllable bleeding and hemorrhages that could not be stopped. Unlike warfarin, whose anticoagulant effects can be reversed using vitamin K, Pradaxa had no reversal agent. That meant that doctors did not have a go-to technique to stop Pradaxa bleeding events.There have been thousands of reports of injuries and hundreds of deaths associated with Pradaxa use since it was introduced by Boehringer Ingelheim.ย ISMP tracked those thousands of Pradaxa adverse event reports, and rated the drug as the medication with the highest number of complaints to the FDA.Ultimately, Boehringer Ingelheim faced about 4,000 Pradaxa bleeding lawsuits, and last month the company announced an agreement to settle the Pradaxa litigation for $650 million. The company is now also working on a Pradaxa reversal agent to help doctors control bleeding events. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Boehringer Ingelheim, Drug Side Effects, PradaxaMore Lawsuit Stories Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials November 11, 2026 Google Gemini AI Lawsuit Alleges Chatbot Encouraged 13-Year-Old Girl to Plan Suicide November 11, 2026 Dupixent CTCL Lawsuits Can Be Directly Filed in Federal MDL November 11, 2026 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: today)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026) Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: yesterday)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITGabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026) FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: 2 days ago)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials November 11, 2026
Google Gemini AI Lawsuit Alleges Chatbot Encouraged 13-Year-Old Girl to Plan Suicide November 11, 2026
Lawyers Outline Process for Settling Bard PowerPort Lawsuits After Bellwether Trials (Posted: today)Attorneys in Bard PowerPort lawsuits have asked a federal judge to suspend pretrial proceedings while the parties engage in settlement negotiations seeking to resolve the litigation.MORE ABOUT: BARD POWERPORT LAWSUITBard PowerPort Infection Lawsuit Claims Catheter Fractures Harbored Bacteria (11/03/2026)Fourth Bard PowerPort Bellwether Case Set for Trial Dec. 1, as Third Gets Underway (10/14/2026)Judge Clears Bard PowerPort Lawsuit for Trial, Rejecting Motion for Summary Judgment (10/02/2026)
Neurontin Dementia Lawsuit Alleges Gabapentin Caused Early-Onset Memory Loss (Posted: yesterday)A womanโs lawsuit claims prolonged use of gabapentin to treat nerve pain resulted in significant memory problems, cognitive decline and early-onset dementia.MORE ABOUT: GABAPENTIN DEMENTIA LAWSUITGabapentin Dementia Risks May Result in Lawsuits Against Drug Maker (09/17/2026)
FDA Requires New Vision Loss Warnings for Ozempic, Wegovy and Other GLP-1s Over NAION Risk (Posted: 2 days ago)Federal regulators are requiring all GLP-1 medications to carry new label warnings indicating the side effects could put patients at risk of sudden and permanent vision loss.MORE ABOUT: OZEMPIC LAWSUITOzempic Blindness Lawsuit Alleges Novo Nordisk Concealed NAION Risks (10/30/2026)GLP-1 Vision Loss Lawsuit Alleges Ozempic Caused Man to Become Legally Blind (10/13/2026)Ozempic Injection Lawsuit Claims Diabetes Medication Caused Vision Loss (09/22/2026)